Table 2.

The number and percentage of papers that included dose-response data for each adenovirus serotype.

Human	Non-Human Primates
Ad5 (16, 46%) [22,24,25,29,31,33,34,38,39,42,43,44,45,46,49,50]	ChAd63 (3, 9%) [24,30,43]
Ad35 (9, 26%) [19,21,23,24,26,28,35,36,39]	ChAd3 (3, 9%) [16,17,24]
Ad26 (4, 11%) [26,27,32,37]	AdC6 (1, 3%) [41]
Ad6 (2, 6%) [38,47]	AdC7 (1, 3%) [40]
Ad28 (1, 3%) [24]	sAd11 (1, 3%) [24]
	sAd16 (1, 3%) [24]
	sAdv-36 (1, 3%) [48]
	ChAdOx1 (1, 3%) [20]